ES2732734T3 - Sistemas de modulación de corriente continua transespinal campo - Google Patents
Sistemas de modulación de corriente continua transespinal campo Download PDFInfo
- Publication number
- ES2732734T3 ES2732734T3 ES14872635T ES14872635T ES2732734T3 ES 2732734 T3 ES2732734 T3 ES 2732734T3 ES 14872635 T ES14872635 T ES 14872635T ES 14872635 T ES14872635 T ES 14872635T ES 2732734 T3 ES2732734 T3 ES 2732734T3
- Authority
- ES
- Spain
- Prior art keywords
- stimulation
- spinal
- nerve
- electrodes
- electrode
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000000638 stimulation Effects 0.000 claims abstract description 196
- 210000005036 nerve Anatomy 0.000 claims abstract description 121
- 210000000056 organ Anatomy 0.000 claims abstract description 67
- 239000012636 effector Substances 0.000 claims abstract description 56
- 230000000694 effects Effects 0.000 claims abstract description 29
- 230000033228 biological regulation Effects 0.000 claims abstract description 28
- 210000005250 spinal neuron Anatomy 0.000 claims abstract description 5
- 241000251539 Vertebrata <Metazoa> Species 0.000 claims abstract description 3
- 210000003205 muscle Anatomy 0.000 claims description 142
- 238000011282 treatment Methods 0.000 claims description 40
- 210000000278 spinal cord Anatomy 0.000 claims description 35
- 230000007383 nerve stimulation Effects 0.000 claims description 10
- 230000001537 neural effect Effects 0.000 description 64
- 230000001965 increasing effect Effects 0.000 description 42
- 230000001734 parasympathetic effect Effects 0.000 description 37
- 230000002889 sympathetic effect Effects 0.000 description 34
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 33
- 230000004007 neuromodulation Effects 0.000 description 30
- 230000006870 function Effects 0.000 description 28
- 230000002093 peripheral effect Effects 0.000 description 27
- 210000005070 sphincter Anatomy 0.000 description 26
- 239000000835 fiber Substances 0.000 description 24
- 208000008238 Muscle Spasticity Diseases 0.000 description 23
- 208000035475 disorder Diseases 0.000 description 23
- 208000018198 spasticity Diseases 0.000 description 23
- 238000000034 method Methods 0.000 description 22
- 206010001497 Agitation Diseases 0.000 description 21
- 230000008602 contraction Effects 0.000 description 19
- 230000003828 downregulation Effects 0.000 description 19
- 210000002161 motor neuron Anatomy 0.000 description 17
- 230000005764 inhibitory process Effects 0.000 description 16
- 230000005284 excitation Effects 0.000 description 15
- 210000000578 peripheral nerve Anatomy 0.000 description 15
- 230000005856 abnormality Effects 0.000 description 14
- 210000002569 neuron Anatomy 0.000 description 14
- 230000010287 polarization Effects 0.000 description 14
- 230000003827 upregulation Effects 0.000 description 14
- 230000007423 decrease Effects 0.000 description 13
- 230000002829 reductive effect Effects 0.000 description 13
- 230000003247 decreasing effect Effects 0.000 description 12
- 210000001617 median nerve Anatomy 0.000 description 12
- 210000005095 gastrointestinal system Anatomy 0.000 description 11
- 210000001153 interneuron Anatomy 0.000 description 11
- 230000000392 somatic effect Effects 0.000 description 11
- 238000004364 calculation method Methods 0.000 description 10
- 201000010099 disease Diseases 0.000 description 10
- 230000004899 motility Effects 0.000 description 10
- 230000028327 secretion Effects 0.000 description 10
- 208000020431 spinal cord injury Diseases 0.000 description 10
- 241000282414 Homo sapiens Species 0.000 description 9
- 210000004556 brain Anatomy 0.000 description 9
- 238000002567 electromyography Methods 0.000 description 9
- 230000001105 regulatory effect Effects 0.000 description 9
- 208000003098 Ganglion Cysts Diseases 0.000 description 8
- 208000005400 Synovial Cyst Diseases 0.000 description 8
- 230000004913 activation Effects 0.000 description 8
- 230000004064 dysfunction Effects 0.000 description 8
- 230000014759 maintenance of location Effects 0.000 description 8
- 230000008855 peristalsis Effects 0.000 description 8
- 230000001953 sensory effect Effects 0.000 description 8
- 210000001186 vagus nerve Anatomy 0.000 description 8
- 206010046555 Urinary retention Diseases 0.000 description 7
- 210000002216 heart Anatomy 0.000 description 7
- 210000000813 small intestine Anatomy 0.000 description 7
- 210000002466 splanchnic nerve Anatomy 0.000 description 7
- 210000000331 sympathetic ganglia Anatomy 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 201000010374 Down Syndrome Diseases 0.000 description 6
- 208000034347 Faecal incontinence Diseases 0.000 description 6
- 241000282412 Homo Species 0.000 description 6
- 206010020852 Hypertonia Diseases 0.000 description 6
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 6
- 238000013459 approach Methods 0.000 description 6
- 210000003403 autonomic nervous system Anatomy 0.000 description 6
- 210000003169 central nervous system Anatomy 0.000 description 6
- 206010008129 cerebral palsy Diseases 0.000 description 6
- 210000003811 finger Anatomy 0.000 description 6
- 230000001976 improved effect Effects 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 210000001002 parasympathetic nervous system Anatomy 0.000 description 6
- 210000002820 sympathetic nervous system Anatomy 0.000 description 6
- 210000000225 synapse Anatomy 0.000 description 6
- 210000003813 thumb Anatomy 0.000 description 6
- 230000003187 abdominal effect Effects 0.000 description 5
- 230000002490 cerebral effect Effects 0.000 description 5
- 230000001684 chronic effect Effects 0.000 description 5
- 210000004907 gland Anatomy 0.000 description 5
- 210000000194 hypogastric plexus Anatomy 0.000 description 5
- 210000000118 neural pathway Anatomy 0.000 description 5
- 230000010004 neural pathway Effects 0.000 description 5
- 230000000926 neurological effect Effects 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 210000003497 sciatic nerve Anatomy 0.000 description 5
- 210000002460 smooth muscle Anatomy 0.000 description 5
- 210000001032 spinal nerve Anatomy 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 210000003699 striated muscle Anatomy 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- 206010020772 Hypertension Diseases 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 208000001089 Multiple system atrophy Diseases 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 208000006011 Stroke Diseases 0.000 description 4
- 230000002567 autonomic effect Effects 0.000 description 4
- 210000001185 bone marrow Anatomy 0.000 description 4
- 210000000133 brain stem Anatomy 0.000 description 4
- 230000006735 deficit Effects 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 230000003907 kidney function Effects 0.000 description 4
- 210000003127 knee Anatomy 0.000 description 4
- 210000002414 leg Anatomy 0.000 description 4
- 230000003902 lesion Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000001465 metallisation Methods 0.000 description 4
- 201000006417 multiple sclerosis Diseases 0.000 description 4
- 210000004126 nerve fiber Anatomy 0.000 description 4
- 210000000653 nervous system Anatomy 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 230000029058 respiratory gaseous exchange Effects 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 238000007665 sagging Methods 0.000 description 4
- 210000002027 skeletal muscle Anatomy 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 230000001148 spastic effect Effects 0.000 description 4
- 230000004936 stimulating effect Effects 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 210000003384 transverse colon Anatomy 0.000 description 4
- 210000003708 urethra Anatomy 0.000 description 4
- 230000002747 voluntary effect Effects 0.000 description 4
- 206010003840 Autonomic nervous system imbalance Diseases 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 206010021118 Hypotonia Diseases 0.000 description 3
- 208000026350 Inborn Genetic disease Diseases 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- 208000007379 Muscle Hypotonia Diseases 0.000 description 3
- 206010028343 Muscle tone abnormalities Diseases 0.000 description 3
- 208000008589 Obesity Diseases 0.000 description 3
- 208000018737 Parkinson disease Diseases 0.000 description 3
- 206010046543 Urinary incontinence Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 210000004100 adrenal gland Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 210000003461 brachial plexus Anatomy 0.000 description 3
- 208000029028 brain injury Diseases 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000004590 computer program Methods 0.000 description 3
- 210000003099 femoral nerve Anatomy 0.000 description 3
- 208000016361 genetic disease Diseases 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000009931 harmful effect Effects 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 235000020824 obesity Nutrition 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 210000004345 peroneal nerve Anatomy 0.000 description 3
- 210000000664 rectum Anatomy 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 230000009885 systemic effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 210000000658 ulnar nerve Anatomy 0.000 description 3
- 230000002485 urinary effect Effects 0.000 description 3
- 208000003116 Adie Syndrome Diseases 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 2
- 206010007559 Cardiac failure congestive Diseases 0.000 description 2
- 206010066131 Congenital central hypoventilation syndrome Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010012559 Developmental delay Diseases 0.000 description 2
- 206010019280 Heart failures Diseases 0.000 description 2
- 206010020352 Holmes-Adie pupil Diseases 0.000 description 2
- 208000016297 Holmes-Adie syndrome Diseases 0.000 description 2
- 208000028389 Nerve injury Diseases 0.000 description 2
- 206010031127 Orthostatic hypotension Diseases 0.000 description 2
- 206010063080 Postural orthostatic tachycardia syndrome Diseases 0.000 description 2
- 102100028255 Renin Human genes 0.000 description 2
- 108090000783 Renin Proteins 0.000 description 2
- 208000009106 Shy-Drager Syndrome Diseases 0.000 description 2
- 208000030886 Traumatic Brain injury Diseases 0.000 description 2
- 206010047139 Vasoconstriction Diseases 0.000 description 2
- 208000004557 Vasovagal Syncope Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 210000004079 adrenergic fiber Anatomy 0.000 description 2
- 210000001815 ascending colon Anatomy 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 230000001363 autoimmune Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000007883 bronchodilation Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 210000001731 descending colon Anatomy 0.000 description 2
- 230000001687 destabilization Effects 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000002550 fecal effect Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 210000004247 hand Anatomy 0.000 description 2
- 239000007943 implant Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000005072 internal anal sphincter Anatomy 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 210000001595 mastoid Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000008035 nerve activity Effects 0.000 description 2
- 230000007830 nerve conduction Effects 0.000 description 2
- 230000008764 nerve damage Effects 0.000 description 2
- 230000003227 neuromodulating effect Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 210000001428 peripheral nervous system Anatomy 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- 238000011458 pharmacological treatment Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000011514 reflex Effects 0.000 description 2
- 230000036332 sexual response Effects 0.000 description 2
- 201000007770 spastic cerebral palsy Diseases 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000011477 surgical intervention Methods 0.000 description 2
- 206010042772 syncope Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000000115 thoracic cavity Anatomy 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 230000009529 traumatic brain injury Effects 0.000 description 2
- 210000000623 ulna Anatomy 0.000 description 2
- 210000001364 upper extremity Anatomy 0.000 description 2
- 230000025033 vasoconstriction Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010052813 Aerophagia Diseases 0.000 description 1
- 206010056948 Automatic bladder Diseases 0.000 description 1
- 208000012639 Balance disease Diseases 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 208000012239 Developmental disease Diseases 0.000 description 1
- 206010051153 Diabetic gastroparesis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 208000014094 Dystonic disease Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 102000003951 Erythropoietin Human genes 0.000 description 1
- 108090000394 Erythropoietin Proteins 0.000 description 1
- 208000000289 Esophageal Achalasia Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000001730 Familial dysautonomia Diseases 0.000 description 1
- 206010020853 Hypertonic bladder Diseases 0.000 description 1
- 206010021518 Impaired gastric emptying Diseases 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 206010027439 Metal poisoning Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 206010030136 Oesophageal achalasia Diseases 0.000 description 1
- 208000009722 Overactive Urinary Bladder Diseases 0.000 description 1
- 208000012868 Overgrowth Diseases 0.000 description 1
- 206010033892 Paraplegia Diseases 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 208000005793 Restless legs syndrome Diseases 0.000 description 1
- 201000001638 Riley-Day syndrome Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 208000032930 Spastic paraplegia Diseases 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 201000000621 achalasia Diseases 0.000 description 1
- 230000036982 action potential Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000001800 adrenalinergic effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 210000004960 anterior grey column Anatomy 0.000 description 1
- 210000003056 antler Anatomy 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000037007 arousal Effects 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 210000000467 autonomic pathway Anatomy 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 208000014797 chronic intestinal pseudoobstruction Diseases 0.000 description 1
- 230000008867 communication pathway Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 208000010118 dystonia Diseases 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 229940105423 erythropoietin Drugs 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000005071 external anal sphincter Anatomy 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000000609 ganglia Anatomy 0.000 description 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 208000001288 gastroparesis Diseases 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 208000024798 heartburn Diseases 0.000 description 1
- 208000010501 heavy metal poisoning Diseases 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 210000000514 hepatopancreas Anatomy 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000003585 interneuronal effect Effects 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000000412 mechanoreceptor Anatomy 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000007659 motor function Effects 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 108091008709 muscle spindles Proteins 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000003767 neural control Effects 0.000 description 1
- 230000007971 neurological deficit Effects 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 208000020629 overactive bladder Diseases 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 210000005034 parasympathetic neuron Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 231100000857 poor renal function Toxicity 0.000 description 1
- 230000018656 positive regulation of gluconeogenesis Effects 0.000 description 1
- 210000004664 postganglionic parasympathetic fiber Anatomy 0.000 description 1
- 210000001089 postganglionic sympathetic fiber Anatomy 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 210000000063 presynaptic terminal Anatomy 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 210000002979 radial nerve Anatomy 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008085 renal dysfunction Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 210000001044 sensory neuron Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 208000013363 skeletal muscle disease Diseases 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 210000004514 sphincter of oddi Anatomy 0.000 description 1
- 210000003594 spinal ganglia Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000004281 subthalamic nucleus Anatomy 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000036409 touch and pain Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 201000001988 urethral stricture Diseases 0.000 description 1
- 208000029584 urinary system neoplasm Diseases 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 210000003857 wrist joint Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0456—Specially adapted for transcutaneous electrical nerve stimulation [TENS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0551—Spinal or peripheral nerve electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/08—Arrangements or circuits for monitoring, protecting, controlling or indicating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/205—Applying electric currents by contact electrodes continuous direct currents for promoting a biological process
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36003—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of motor muscles, e.g. for walking assistance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/3603—Control systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36062—Spinal stimulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/3615—Intensity
- A61N1/36157—Current
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/3615—Intensity
- A61N1/3616—Voltage density or current density
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Biophysics (AREA)
- Electrotherapy Devices (AREA)
- Magnetic Treatment Devices (AREA)
- Steroid Compounds (AREA)
- Gastroenterology & Hepatology (AREA)
- Amplifiers (AREA)
- Amplitude Modulation (AREA)
- Stabilization Of Oscillater, Synchronisation, Frequency Synthesizers (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361919806P | 2013-12-22 | 2013-12-22 | |
| US201461925423P | 2014-01-09 | 2014-01-09 | |
| US201462092214P | 2014-12-15 | 2014-12-15 | |
| PCT/US2014/071959 WO2015095880A2 (en) | 2013-12-22 | 2014-12-22 | Trans-spinal direct current modulation systems |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2732734T3 true ES2732734T3 (es) | 2019-11-25 |
Family
ID=53403908
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES14872635T Active ES2732734T3 (es) | 2013-12-22 | 2014-12-22 | Sistemas de modulación de corriente continua transespinal campo |
| ES19161879T Active ES2889099T3 (es) | 2013-12-22 | 2014-12-22 | Sistemas de modulación de corriente continua transespinal |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES19161879T Active ES2889099T3 (es) | 2013-12-22 | 2014-12-22 | Sistemas de modulación de corriente continua transespinal |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US9283391B2 (https=) |
| EP (2) | EP3082947B1 (https=) |
| JP (1) | JP6518251B2 (https=) |
| KR (2) | KR20160105822A (https=) |
| CN (2) | CN106029164B (https=) |
| AU (1) | AU2014368874B2 (https=) |
| CA (1) | CA2932000C (https=) |
| CY (1) | CY1122116T1 (https=) |
| DK (1) | DK3082947T3 (https=) |
| ES (2) | ES2732734T3 (https=) |
| HR (1) | HRP20191032T1 (https=) |
| HU (1) | HUE045175T2 (https=) |
| IL (1) | IL246430B (https=) |
| LT (1) | LT3082947T (https=) |
| MX (1) | MX366919B (https=) |
| PL (1) | PL3082947T3 (https=) |
| PT (1) | PT3082947T (https=) |
| SG (1) | SG11201604288WA (https=) |
| SI (1) | SI3082947T1 (https=) |
| WO (1) | WO2015095880A2 (https=) |
Families Citing this family (101)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9211410B2 (en) | 2009-05-01 | 2015-12-15 | Setpoint Medical Corporation | Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation |
| WO2014169145A1 (en) | 2013-04-10 | 2014-10-16 | Setpoint Medical Corporation | Closed-loop vagus nerve stimulation |
| US12172017B2 (en) | 2011-05-09 | 2024-12-24 | Setpoint Medical Corporation | Vagus nerve stimulation to treat neurodegenerative disorders |
| US9415218B2 (en) | 2011-11-11 | 2016-08-16 | The Regents Of The University Of California | Transcutaneous spinal cord stimulation: noninvasive tool for activation of locomotor circuitry |
| WO2013134543A1 (en) | 2012-03-08 | 2013-09-12 | Medtronic Ardian Luxembourg Sarl | Immune system neuromodulation and associated systems and methods |
| US10195434B2 (en) | 2012-06-15 | 2019-02-05 | Case Western Reserve University | Treatment of pain using electrical nerve conduction block |
| JP6426085B2 (ja) | 2012-06-15 | 2018-11-21 | ケース ウェスタン リザーブ ユニバーシティＣａｓｅ Ｗｅｓｔｅｒｎ Ｒｅｓｅｒｖｅ Ｕｎｉｖｅｒｓｉｔｙ | 損傷のない神経組織伝導ブロック用の治療送達装置および方法 |
| US12453853B2 (en) | 2013-01-21 | 2025-10-28 | Cala Health, Inc. | Multi-modal stimulation for treating tremor |
| EP3498332B1 (en) | 2013-01-21 | 2021-07-14 | Cala Health, Inc. | Devices for controlling tremor |
| AU2014228794B2 (en) | 2013-03-15 | 2019-04-18 | The Regents Of The University Of California | Multi-site transcutaneous electrical stimulation of the spinal cord for facilitation of locomotion |
| US20150238764A1 (en) | 2013-05-10 | 2015-08-27 | Case Western Reserve University | Systems and methods for preventing noise in an electric waveform for neural stimulation, block, or sensing |
| WO2014194200A1 (en) | 2013-05-30 | 2014-12-04 | Creasey Graham H | Topical neurological stimulation |
| US11229789B2 (en) | 2013-05-30 | 2022-01-25 | Neurostim Oab, Inc. | Neuro activator with controller |
| CA2924817C (en) | 2013-09-16 | 2023-09-19 | The Board Of Trustees Of The Leland Stanford Junior University | Multi-element coupler for generation of electromagnetic energy |
| US10137299B2 (en) | 2013-09-27 | 2018-11-27 | The Regents Of The University Of California | Engaging the cervical spinal cord circuitry to re-enable volitional control of hand function in tetraplegic subjects |
| US9707390B2 (en) * | 2013-12-22 | 2017-07-18 | The Research Foundation Of The City University Of New York | Apparatus for modulation of effector organs |
| US9707391B2 (en) * | 2013-12-22 | 2017-07-18 | The Research Foundation Of The City University Of New York | Method for modulation of effector organs |
| LT3082947T (lt) * | 2013-12-22 | 2019-07-10 | Research Foundation Of The City University Of New York | Transspinalinės nuolatinės srovės moduliavimo sistemos |
| US20160336813A1 (en) | 2015-05-15 | 2016-11-17 | NeuSpera Medical Inc. | Midfield coupler |
| WO2015179225A1 (en) | 2014-05-18 | 2015-11-26 | Yeh Alexander Jueshyan | Midfield coupler |
| EP3145581B1 (de) * | 2014-05-23 | 2019-07-03 | Albrecht Molsberger | Therapeutisch anwendbare mehrkanal- gleichstromabgabevorrichtung |
| AU2015271774B2 (en) | 2014-06-02 | 2020-04-16 | Cala Health, Inc. | Systems and methods for peripheral nerve stimulation to treat tremor |
| AU2015305237B2 (en) | 2014-08-21 | 2020-06-18 | The Regents Of The University Of California | Regulation of autonomic control of bladder voiding after a complete spinal cord injury |
| EP3185946B1 (en) | 2014-08-27 | 2019-10-09 | The Regents Of The University Of California | Multi-electrode array for spinal cord epidural stimulation |
| US11311725B2 (en) | 2014-10-24 | 2022-04-26 | Setpoint Medical Corporation | Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation |
| JP2017536187A (ja) | 2014-12-03 | 2017-12-07 | メタベンション インコーポレイテッド | 神経または他の組織を調節するためのシステムおよび方法 |
| US11077301B2 (en) | 2015-02-21 | 2021-08-03 | NeurostimOAB, Inc. | Topical nerve stimulator and sensor for bladder control |
| CN119565022A (zh) | 2015-06-10 | 2025-03-07 | 卡拉健康公司 | 用于外周神经刺激以利用可拆卸治疗和监测单元治疗震颤的系统和方法 |
| WO2017023864A1 (en) | 2015-07-31 | 2017-02-09 | Cala Health, Inc. | Systems, devices, and method for the treatment of osteoarthritis |
| BR112018002218A2 (pt) * | 2015-08-03 | 2018-09-04 | Univ Duke | aparelho para modular a atividade neural de fibras aferentes, método para tratamento de disfunção da bexiga, forma de onda elétrica neuromodulatória, uso de um aparelho de neuromodulação, composição farmacêutica, e, sistema de neuromodulação |
| US11007368B2 (en) | 2015-08-19 | 2021-05-18 | University Of Louisville Research Foundation, Inc. | Methods for providing optimized neurostimulation |
| US11298533B2 (en) | 2015-08-26 | 2022-04-12 | The Regents Of The University Of California | Concerted use of noninvasive neuromodulation device with exoskeleton to enable voluntary movement and greater muscle activation when stepping in a chronically paralyzed subject |
| AU2016320803A1 (en) * | 2015-09-08 | 2018-03-22 | Case Western Reserve University | Systems and methods for transcutaneous direct current block to alter nerve conduction |
| EP3352843B1 (en) | 2015-09-23 | 2021-06-23 | Cala Health, Inc. | Device for peripheral nerve stimulation in the finger to treat hand tremors |
| WO2017062272A1 (en) | 2015-10-06 | 2017-04-13 | Case Western Reserve University | High-charge capacity electrodes to deliver direct current nerve conduction block |
| US11097122B2 (en) | 2015-11-04 | 2021-08-24 | The Regents Of The University Of California | Magnetic stimulation of the spinal cord to restore control of bladder and/or bowel |
| US10864373B2 (en) | 2015-12-15 | 2020-12-15 | Case Western Reserve University | Systems for treatment of a neurological disorder using electrical nerve conduction block |
| US11471681B2 (en) | 2016-01-20 | 2022-10-18 | Setpoint Medical Corporation | Batteryless implantable microstimulators |
| CN108882885A (zh) | 2016-01-20 | 2018-11-23 | 赛博恩特医疗器械公司 | 迷走神经刺激的控制 |
| WO2017132067A2 (en) * | 2016-01-21 | 2017-08-03 | Cala Health, Inc. | Systems, methods and devices for peripheral neuromodulation for treating diseases related to overactive bladder |
| US10583304B2 (en) | 2016-01-25 | 2020-03-10 | Setpoint Medical Corporation | Implantable neurostimulator having power control and thermal regulation and methods of use |
| US10524859B2 (en) | 2016-06-07 | 2020-01-07 | Metavention, Inc. | Therapeutic tissue modulation devices and methods |
| IL264116B2 (en) * | 2016-07-08 | 2024-01-01 | Cala Health Inc | Systems and methods for stimulating n nerves with exactly n electrodes and improved dry electrodes |
| CN109803717B (zh) | 2016-08-25 | 2024-01-09 | 卡拉健康公司 | 通过周围神经刺激治疗心脏机能障碍的系统和方法 |
| AU2017251817A1 (en) * | 2016-11-04 | 2018-05-24 | Gimer Medical. Co. Ltd. | Method for reducing overactive bladder syndrome and computer-readable medium thereof |
| AU2017254920B2 (en) * | 2016-11-10 | 2019-04-04 | Gimer Medical Co. Ltd. | Method of reducing renal hypertension and computer-readable medium |
| EP3551280B1 (en) | 2016-12-12 | 2023-08-09 | The Regents of the University of California | Implantable and non-invasive stimulators for gastrointestinal therapeutics |
| EP3558447B1 (en) | 2016-12-20 | 2022-07-06 | Galvani Bioelectronics Limited | Neuromodulation device |
| CN117100245A (zh) | 2017-01-05 | 2023-11-24 | 诺克特丽克丝健康公司 | 不宁腿综合征或过度活跃神经治疗 |
| US11103691B2 (en) | 2019-10-03 | 2021-08-31 | Noctrix Health, Inc. | Peripheral nerve stimulation for restless legs syndrome |
| US11235154B2 (en) | 2017-02-17 | 2022-02-01 | The University Of British Columbia | Apparatus and methods for maintaining physiological functions |
| EP3606604A4 (en) | 2017-04-03 | 2020-12-16 | Cala Health, Inc. | PERIPHERAL NEUROMODULATION SYSTEMS, METHODS AND DEVICES FOR THE TREATMENT OF DISEASES ASSOCIATED WITH BLADDER HYPERACTIVITY |
| EP3606599A4 (en) | 2017-04-03 | 2021-01-13 | Presidio Medical, Inc. | SYSTEMS AND PROCEDURES FOR A DC NERVOUS GUIDE BLOCK |
| WO2018217791A1 (en) | 2017-05-23 | 2018-11-29 | The Regents Of The University Of California | Accessing spinal networks to address sexual dysfunction |
| DE20168827T1 (de) | 2017-06-30 | 2021-01-21 | Gtx Medical B.V. | System zur neuromodulierung |
| US11173307B2 (en) | 2017-08-14 | 2021-11-16 | Setpoint Medical Corporation | Vagus nerve stimulation pre-screening test |
| EP3706856A4 (en) | 2017-11-07 | 2021-08-18 | Neurostim Oab, Inc. | NON-INVASIVE NERVOUS ACTIVATOR WITH ADAPTIVE CIRCUIT |
| ES3058711T3 (en) | 2017-12-05 | 2026-03-12 | Ecole Polytechnique Fed Lausanne Epfl | A system for planning and/or providing neuromodulation |
| US12357828B2 (en) | 2017-12-05 | 2025-07-15 | Ecole Polytechnique Federale De Lausanne (Epfl) | System for planning and/or providing neuromodulation |
| CN109999341A (zh) * | 2018-01-04 | 2019-07-12 | 精能医学股份有限公司 | 电刺激器、制造电刺激器的方法及电刺激系统 |
| CN110013605A (zh) * | 2018-01-10 | 2019-07-16 | 精能医学股份有限公司 | 电刺激器、治疗方法及电刺激系统 |
| US11857778B2 (en) | 2018-01-17 | 2024-01-02 | Cala Health, Inc. | Systems and methods for treating inflammatory bowel disease through peripheral nerve stimulation |
| CN118557272A (zh) | 2018-02-09 | 2024-08-30 | 普雷西迪奥医学有限公司 | 用于心脏传导阻滞的系统和方法 |
| ES2947433T3 (es) | 2018-02-20 | 2023-08-09 | Presidio Medical Inc | Sistemas para bloqueo de conducción nerviosa |
| KR102141550B1 (ko) | 2018-03-14 | 2020-08-05 | 이화여자대학교 산학협력단 | 비침습적 방광 배뇨 관리 시스템 |
| US11986659B2 (en) | 2018-03-22 | 2024-05-21 | Research Foundation Of The City University Of New York | Modulation of neuronal NKCC1 as a therapeutic strategy for spasticity and related disorders |
| US11207520B2 (en) | 2018-05-17 | 2021-12-28 | Regents Of The University Of Minnesota | System and method for controlling blood pressure |
| US11752329B2 (en) | 2018-07-01 | 2023-09-12 | Presidio Medical, Inc. | Systems and methods for nerve conduction block |
| WO2020014336A1 (en) * | 2018-07-11 | 2020-01-16 | Dignify Therapeutics, Llc | Method of treating voiding dysfunction |
| US20210236837A1 (en) * | 2018-08-21 | 2021-08-05 | The Regents Of The University Of California | Transcutaneous electrical and/or magnetic spinal stimulation for bladder or bowel control in subjects without cns injury |
| JP2021534877A (ja) | 2018-08-23 | 2021-12-16 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアThe Regents Of The University Of California | 神経根麻痺、馬尾症候群、及び上肢機能の回復のための非侵襲性脊髄刺激 |
| US11141586B2 (en) * | 2018-08-31 | 2021-10-12 | Avation Medical, Inc. | System, method, and apparatus for applying transcutaneous electrical stimulation |
| US11260229B2 (en) | 2018-09-25 | 2022-03-01 | The Feinstein Institutes For Medical Research | Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation |
| CN109173056B (zh) * | 2018-10-19 | 2022-03-22 | 南通大学 | 一种大鼠脊髓神经信号检测与评估系统及方法 |
| US11602633B2 (en) * | 2018-10-22 | 2023-03-14 | Pathmaker Neurosystems Inc. | Method and apparatus for controlling multi-site neurostimulation |
| ES2911465T3 (es) | 2018-11-13 | 2022-05-19 | Onward Medical N V | Sistema de control para la reconstrucción y/o restauración del movimiento de un paciente |
| EP3695878B1 (en) | 2019-02-12 | 2023-04-19 | ONWARD Medical N.V. | A system for neuromodulation |
| US11617884B2 (en) | 2019-03-15 | 2023-04-04 | Case Western Reserve University | Electrically anesthetizing a peripheral nerve with on-demand electrical nerve block for chronic pain management |
| US12343535B2 (en) | 2019-04-12 | 2025-07-01 | Setpoint Medical Corporation | Vagus nerve stimulation to treat neurodegenerative disorders |
| US20220305268A1 (en) * | 2019-06-19 | 2022-09-29 | Galvani Bioelectronics Limited | Neuromodulation Device |
| US11458311B2 (en) | 2019-06-26 | 2022-10-04 | Neurostim Technologies Llc | Non-invasive nerve activator patch with adaptive circuit |
| WO2021022020A1 (en) | 2019-07-30 | 2021-02-04 | Duke University | Devices, systems, and methods for promoting voiding in subjects with underactive bladders |
| US12251560B1 (en) | 2019-08-13 | 2025-03-18 | Cala Health, Inc. | Connection quality determination for wearable neurostimulation systems |
| US11890468B1 (en) | 2019-10-03 | 2024-02-06 | Cala Health, Inc. | Neurostimulation systems with event pattern detection and classification |
| AU2020358093B2 (en) | 2019-10-03 | 2025-10-23 | Noctrix Health, Inc. | Peripheral nerve stimulation for restless legs syndrome |
| CN110585597B (zh) * | 2019-10-21 | 2024-04-16 | 中南大学湘雅三医院 | 肠道蠕动智能调节系统 |
| US11730964B2 (en) | 2019-11-24 | 2023-08-22 | Presidio Medical, Inc. | Pulse generation and stimulation engine systems |
| US12268865B2 (en) | 2019-11-24 | 2025-04-08 | Presidio Medical, Inc. | Current bias as a control mechanism for electrode operation |
| EP3827875B1 (en) | 2019-11-27 | 2023-07-05 | ONWARD Medical N.V. | Neuromodulation system |
| DE19211698T1 (de) | 2019-11-27 | 2021-09-02 | Onward Medical B.V. | Neuromodulation system |
| KR20220115802A (ko) | 2019-12-16 | 2022-08-18 | 뉴로스팀 테크놀로지스 엘엘씨 | 부스트 전하 전달 기능이 있는 비침습적 신경 액티베이터 |
| US11938324B2 (en) | 2020-05-21 | 2024-03-26 | The Feinstein Institutes For Medical Research | Systems and methods for vagus nerve stimulation |
| US12208266B2 (en) * | 2020-05-26 | 2025-01-28 | Research Foundation Of The City University Of New York | Multi-site neuromodulation for treatment of ALS and related disorders |
| EP3915470A1 (en) * | 2020-05-26 | 2021-12-01 | ONWARD Medical B.V. | Neuromodulation and/or neurostimulation system |
| KR102554540B1 (ko) * | 2020-07-30 | 2023-07-12 | 재단법인대구경북과학기술원 | 맞춤형 전기 자극 제공 시스템 및 그 방법 |
| EP4304706B1 (en) | 2021-03-12 | 2025-07-30 | Amber Therapeutics Holdings Limited | Systems for incontinence control |
| WO2022245878A1 (en) | 2021-05-17 | 2022-11-24 | Setpoint Medical Corporation | Neurostimulation parameter authentication and expiration system for neurostimulation |
| US20250229086A1 (en) | 2022-01-20 | 2025-07-17 | Setpoint Medical Corporation | Treatment of inflammatory disorders |
| EP4694965A1 (en) * | 2023-04-10 | 2026-02-18 | The United States of America, as represented by the Secretary, Department of Health and Human Services | Systems and methods for multichannel individualized stimulation therapy |
| WO2025094661A1 (ja) * | 2023-11-02 | 2025-05-08 | 国立大学法人大阪大学 | 機能的電気刺激装置および機能的電気刺激システム |
| WO2025254758A1 (en) * | 2024-06-05 | 2025-12-11 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Systems and methods for adjustable current individualized stimulation therapy |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5193539A (en) | 1991-12-18 | 1993-03-16 | Alfred E. Mann Foundation For Scientific Research | Implantable microstimulator |
| US6366814B1 (en) * | 1998-10-26 | 2002-04-02 | Birinder R. Boveja | External stimulator for adjunct (add-on) treatment for neurological, neuropsychiatric, and urological disorders |
| US20060122660A1 (en) * | 1998-10-26 | 2006-06-08 | Boveja Birinder R | Method and system for modulating sacral nerves and/or its branches in a patient to provide therapy for urological disorders and/or fecal incontinence, using rectangular and/or complex electrical pulses |
| US6353762B1 (en) * | 1999-04-30 | 2002-03-05 | Medtronic, Inc. | Techniques for selective activation of neurons in the brain, spinal cord parenchyma or peripheral nerve |
| US7155278B2 (en) * | 2003-04-21 | 2006-12-26 | Medtronic, Inc. | Neurostimulation to treat effects of sleep apnea |
| US20100016929A1 (en) * | 2004-01-22 | 2010-01-21 | Arthur Prochazka | Method and system for controlled nerve ablation |
| US20080071321A1 (en) * | 2004-06-10 | 2008-03-20 | Ndi Medical, Inc. | Systems and methods of neuromodulation stimulation for the restoration of sexual function |
| AU2005282379B8 (en) * | 2004-09-08 | 2012-04-05 | Spinal Modulation Inc. | Neurostimulation methods and systems |
| US9205261B2 (en) * | 2004-09-08 | 2015-12-08 | The Board Of Trustees Of The Leland Stanford Junior University | Neurostimulation methods and systems |
| US8644941B2 (en) * | 2005-06-09 | 2014-02-04 | Medtronic, Inc. | Peripheral nerve field stimulation and spinal cord stimulation |
| AU2007207297B2 (en) * | 2006-01-23 | 2011-12-22 | 2249020 Alberta Ltd. | Method of routing electrical current to bodily tissues via implanted passive conductors |
| US8612019B2 (en) * | 2007-05-23 | 2013-12-17 | Boston Scientific Neuromodulation Corporation | Coupled monopolar and multipolar pulsing for conditioning and stimulation |
| US20090204173A1 (en) * | 2007-11-05 | 2009-08-13 | Zi-Ping Fang | Multi-Frequency Neural Treatments and Associated Systems and Methods |
| US8532779B2 (en) * | 2008-10-31 | 2013-09-10 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
| US8996116B2 (en) * | 2009-10-30 | 2015-03-31 | Setpoint Medical Corporation | Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction |
| WO2011050255A2 (en) * | 2009-10-22 | 2011-04-28 | Research Foundation Of The City University Of New York | Dipole electrical stimulation employing direct current for recovery from spinal cord injury |
| MX2012010841A (es) * | 2010-03-22 | 2013-01-29 | Univ City New York Res Found | Sistema de estimulacion electrica neural mejorado de carga. |
| WO2011156287A2 (en) * | 2010-06-07 | 2011-12-15 | Medtronic, Inc. | Selective termination of stimulation to deliver post-stimulation therapeutic effect |
| WO2012003451A2 (en) * | 2010-07-01 | 2012-01-05 | Stimdesigns Llc | Universal closed-loop electrical stimulation system |
| KR20140013043A (ko) * | 2011-03-24 | 2014-02-04 | 캘리포니아 인스티튜트 오브 테크놀로지 | 신경자극기 |
| AU2012304370B2 (en) * | 2011-09-08 | 2016-01-28 | Nevro Corporation | Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods |
| WO2013082022A1 (en) * | 2011-11-29 | 2013-06-06 | Cardiac Pacemakers, Inc. | Autonomic modulation using peripheral nerve field stimulation |
| US8706240B2 (en) * | 2011-12-09 | 2014-04-22 | Boston Scientific Neuromodulation Corporation | Method for direct modulation of the spinothalamic tract |
| JP5997829B2 (ja) * | 2012-03-16 | 2016-09-28 | ボストン サイエンティフィック ニューロモデュレイション コーポレイション | 電圧源を使用したフィールド増強式電流ステアリング |
| EP2825256B1 (en) * | 2012-03-16 | 2021-09-15 | Boston Scientific Neuromodulation Corporation | System for estimating location and depth of stimulation leads |
| JP2016515904A (ja) * | 2013-04-05 | 2016-06-02 | ワシーム アハマド， | 空気流の診断および回復のためのデバイスおよび方法 |
| US9707390B2 (en) * | 2013-12-22 | 2017-07-18 | The Research Foundation Of The City University Of New York | Apparatus for modulation of effector organs |
| US9707391B2 (en) * | 2013-12-22 | 2017-07-18 | The Research Foundation Of The City University Of New York | Method for modulation of effector organs |
| LT3082947T (lt) * | 2013-12-22 | 2019-07-10 | Research Foundation Of The City University Of New York | Transspinalinės nuolatinės srovės moduliavimo sistemos |
-
2014
- 2014-12-22 LT LTEP14872635.9T patent/LT3082947T/lt unknown
- 2014-12-22 CN CN201480070353.7A patent/CN106029164B/zh active Active
- 2014-12-22 WO PCT/US2014/071959 patent/WO2015095880A2/en not_active Ceased
- 2014-12-22 SI SI201431236T patent/SI3082947T1/sl unknown
- 2014-12-22 US US14/579,829 patent/US9283391B2/en active Active
- 2014-12-22 EP EP14872635.9A patent/EP3082947B1/en active Active
- 2014-12-22 ES ES14872635T patent/ES2732734T3/es active Active
- 2014-12-22 HU HUE14872635A patent/HUE045175T2/hu unknown
- 2014-12-22 DK DK14872635.9T patent/DK3082947T3/da active
- 2014-12-22 SG SG11201604288WA patent/SG11201604288WA/en unknown
- 2014-12-22 KR KR1020167020164A patent/KR20160105822A/ko not_active Withdrawn
- 2014-12-22 JP JP2016534630A patent/JP6518251B2/ja active Active
- 2014-12-22 CA CA2932000A patent/CA2932000C/en active Active
- 2014-12-22 EP EP19161879.2A patent/EP3581239B1/en active Active
- 2014-12-22 ES ES19161879T patent/ES2889099T3/es active Active
- 2014-12-22 PT PT14872635T patent/PT3082947T/pt unknown
- 2014-12-22 PL PL14872635T patent/PL3082947T3/pl unknown
- 2014-12-22 AU AU2014368874A patent/AU2014368874B2/en active Active
- 2014-12-22 HR HRP20191032TT patent/HRP20191032T1/hr unknown
- 2014-12-22 CN CN201811512717.9A patent/CN109432596B/zh active Active
- 2014-12-22 KR KR1020197036685A patent/KR102431161B1/ko active Active
- 2014-12-22 MX MX2016007586A patent/MX366919B/es active IP Right Grant
-
2016
- 2016-02-18 US US15/046,797 patent/US9844668B2/en active Active
- 2016-06-20 IL IL246430A patent/IL246430B/en active IP Right Grant
-
2017
- 2017-11-02 US US15/802,020 patent/US10493270B2/en active Active
-
2019
- 2019-06-13 CY CY20191100617T patent/CY1122116T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2732734T3 (es) | Sistemas de modulación de corriente continua transespinal campo | |
| US11529513B2 (en) | Neuromodulation system | |
| US9707390B2 (en) | Apparatus for modulation of effector organs | |
| US9707391B2 (en) | Method for modulation of effector organs | |
| EP3527257A2 (en) | Neuromodulatory systems and methods for treating functional gastrointestinal disorders | |
| US20230121038A1 (en) | Neuromodulation system | |
| EP3319685B1 (en) | Apparatus for modulation of effector organs | |
| US12447336B2 (en) | Treatment of overactive bladder with phase-contingent pudendal nerve stimulation | |
| CN101421003A (zh) | 利用电信号来治疗肠梗阻状况的方法和装置 |